Cipla Recalls Phytonadione Injectable Emulsion Due to Stability Issues
Failed Stability Specifications: Observed OOS results: eg results for colour index
2,090 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
Failed Stability Specifications: Observed OOS results: eg results for colour index
Stryker Medical recalled 286 MV3 bariatric beds on October 31, 2025. The beds may not be compatible with Arise 1000EX mattresses, posing risks to patients. Healthcare providers and patients must stop using the beds immediately.
Philips North America recalled 1,913,441 IntelliVue Patient Monitors on October 31, 2025. The monitors may fail to alarm, posing serious risks to patients. Users must stop using the device immediately and follow the manufacturer's instructions.
Potential issue where the IntelliVue monitors did not alarm.
Dynashield, a 4 oz cream, is recalled after cGMP deviations were identified. The recall affects 7,944 units distributed nationwide. Consumers should stop using the product immediately and contact their healthcare provider for guidance.
Potential issue where the IntelliVue monitors did not alarm.
Potential issue where the IntelliVue monitors did not alarm.
Potential issue where the IntelliVue monitors did not alarm.
Potential issue where the IntelliVue monitors did not alarm.
Stryker recalled 289 Arise 1000EX mattresses on October 31, 2025. The recall affects products sold nationwide due to potential incompatibility with MV3 beds. Users should stop using these mattresses immediately.
Tape used to secure components within packaging contains latex, despite products being labeled as latex-free. Latex could potentially cause an allergic reaction.
Potential issue where the IntelliVue monitors did not alarm.
Dynarex Corporation recalled 18,912 containers of Wecare Enema on October 31, 2025, due to cGMP deviations. Consumers should stop using the product immediately. The recall affects products distributed nationwide in the USA.
Potential issue where the IntelliVue monitors did not alarm.
Potential that the ligation loop was unable to release or detach as expected during use, causing the loop to become unintentionally fixed around patient anatomy.
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.